ENTITY

Propanc Biopharma (PPCB US)

2
Analysis
Health Care • United States
Propanc Biopharma, Inc. is a development-stage healthcare company focused on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. Its lead product candidate, PRP, is a novel formulation involving pro-enzymes, which are the inactive precursors of enzymes.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x